Cara Therapeutics (CARA)

$13.40 0.00 (0.00%)

9:16 EDT CARA Stock Quote Delayed 20 Minutes

Volume:

Previous Close $13.40

Market Cap 453.92M

PE Ratio -8.59

EPS -1.56

Volume (Avg. Vol.) 1,492

Day's Range 13.40 - 13.40

52-Week Range 8.88 - 27.55

Dividend & Yield N/A (N/A)

CARA Stock Predictions, Articles, and Cara Therapeutics News

From InvestorPlace
From the Web

Why This Just Might Be the Biggest Week for CARA Stock

By Chris Lau, InvestorPlace Contributor Nov 5, 2019

Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.

10 Marijuana Stocks That Could See 100% Gains, If Not More

By James Brumley, InvestorPlace Feature Writer Aug 21, 2019

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.

3 Marijuana Stocks to Play the Future of Cannabis Medicine

By Aaron Levitt, InvestorPlace Contributor Aug 6, 2019

Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.

Even with a Pharma Arm, Canopy Growth Stock Is About Recreational Use

By James Brumley, InvestorPlace Feature Writer May 23, 2019

It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.

5 Cannabis Stocks Set to Skyrocket — According to Wall Street’s Top Analysts

By Harriet Lefton, Writer, TipRanks Apr 1, 2019

Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.

Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?

By Ian Bezek, InvestorPlace Contributor Feb 13, 2019

With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.

Compare Brokers

With Trial Results Due, This Could Be a Breakout Year for Cara Stock

By Chris Lau, InvestorPlace Contributor Jan 18, 2019

Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock

Cara Therapeutics Stock Could Outperform in 2019

By James Brumley, InvestorPlace Feature Writer Dec 19, 2018

CARA stock could be meaningfully boosted by drug development updates in 2019

The Trade War Could Be a Positive Catalyst for Cara Therapeutics Stock

By Ian Bezek, InvestorPlace Contributor Dec 3, 2018

Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.

9 Marijuana Stocks to Play the Pot Craze

By James Brumley, InvestorPlace Feature Writer Oct 19, 2018

Marijuana stocks like Cronos, Cannabis Sativa and Canopy Growth are just a handful of the names worth a closer look here.

Why Cara Therapeutics Stock Is Soaring Today

By Karl Utermohlen, InvestorPlace Writer Jun 27, 2018

Cara Therapeutics (CARA) shares were up more than 11% on Wednesday as the company received good news regarding its latest clinical trial.

3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)

By Karl Utermohlen, InvestorPlace Writer Jul 12, 2017

Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.

Compare Brokers